Although the study of ACLY in ccRCC is limited to the comparison of its gene expression levels in different samples to prove the high expression of ACLY in ccRCC samples, several clues have proved that the treatment of ACLY can be applied to the clinical treatment of ccRCC. This evidence concerns the gene ACLY and nonpapillary renal cell carcinoma.